Category Specific RSS

psilocybin

Tryptamine Therapeutics’ psilocybin trials deliver pain relief to all patients

With their new name to reflect the journey their patients undergo when treated with psychedelic drugs, Tryptamine Therapeutics (ASX: TYP)…

11 months ago

Vitura’s Cortexa becomes first Aus company to supply ecstasy and magic mushrooms under TGA’s prescriber scheme

In July last year, Australia became the first country to legalise ecstasy (MDMA) and magic mushrooms (psilocybin) for mental health…

1 year ago

Melodiol reports positive results from Halucenex trials for magic mushrooms to treat PTSD

In Australia, about 43% of people aged between 16 and 85 had experienced a mental disorder at some point as…

2 years ago

Emyria recruits first patient for its meth-assisted therapy to treat PTSD

As news of billionaire (and controversial) business magnate Elon Musk taking “microdoses of ketamine (a dissociative drug)” to manage depression…

2 years ago

Cann Group poised for growth as demand for locally produced cannabis surges

Australia has made a groundbreaking decision by becoming the first country to legalise the clinical prescribing of MDMA (ecstasy) and…

2 years ago

Incannex to launch psychedelic-assisted clinics across Australia

In February 2023, Australia became the first country to accept psychedelics, i.e. hallucinogenic drugs, as medicine. It approved the use…

2 years ago